Huh. Got the PET report today and it's not as "clean" as I thought:
"There remains abnormal radiotracer uptake along the right lateral margin L4/medial margin of the right psoas the corresponds to abnormal postcontrast enhancement on the 4/7/2028 MRI. This is most concerning for residual malignancy but has improved compared to the Jan 17 2019 exam. Maximum SUV measures
5.6 (prior 17.2)". We never heard anything from DH's onc regarding this. From what I've read, SUV above 2.5 is definitely concern for malignancy...
Then I read the surgeon's notes for tomorrow and they say:
"Recommedation: I have recommended that [the patient]
get resection of the tumor and clearance of compression involving the L3 and L4 nerve roots dorsal lateral are delayed fusion using BMP there is no room for structural interbody cages pedicle screw rod construct for spinal reconstruction from L3-5."
I wonder if this means that there is residual tumor and that the surgeon will take it out? I guess I should ask directly, or call the oncologist... But surgery is tomorrow so hopefully answers then? Meanwhile I post here, just to get it out of my head
Wife of Dx 04/18 (51 yo). MSS, KRAS G12A, no primary
Tumors: L4 04/18; left adrenal gland & small lung nodules 03/19
rectum 02/22 (pT3 pN0 stage 2A); L3 09/22
Surgeries: intestinal resect. 05/18 (no cancer - Crohn's); adrenalectomy 02/20
L3-L4-L5 fusion and corpectomy 05/20; LAR 04/22; ileo reversal 09/22
L2-L3 fusion and corpectomy 09/22
Treatments: EBRT 04/18; SBRT 02/19; Failed adjuvant Xelox ; Folfiri/Avastin 03/19 - 01/20
adjuvant chemorad (Xeloda) 06/22; SBRT 11/22; Xeloda/Avastin since 01/24